Teladoc (Germany) Today

4LL Stock  EUR 4.06  0.09  2.27%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Risky

 
High
 
Low
Teladoc is trading at 4.06 as of the 14th of February 2026. This is a 2.27 percent increase since the beginning of the trading day. The stock's lowest day price was 3.71. Teladoc has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of November 2025 and ending today, the 14th of February 2026. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York. TELADOC HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. The company has 177.47 M outstanding shares. More on Teladoc

Moving against Teladoc Stock

  0.92ECK LUDWIG BECKPairCorr
  0.85TKDA Takeda PharmaceuticalPairCorr
  0.84MO7R MOOG INC CLPairCorr
  0.846HW BANK HANDLOWYPairCorr
  0.83KEP1 Keppel LimitedPairCorr
  0.82SGJH Sinopec Shanghai PetPairCorr

Teladoc Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Teladoc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Teladoc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO DirectorCPA III
Business ConcentrationHealth Care Technology, Health Care Equipment & Services, Health Care, Health Care, Health Care Technology, Health Information Services, Healthcare (View all Sectors)
Teladoc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Teladoc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Teladoc utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Teladoc's leverage profile, showing how much of Teladoc's resources are funded through borrowing.
Liquidity
Teladoc cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Teladoc has accumulated 550.72 M in total debt with debt to equity ratio (D/E) of 0.09, which may suggest the company is not taking enough advantage from borrowing. Teladoc has a current ratio of 3.88, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Teladoc until it has trouble settling it off, either with new capital or with free cash flow. So, Teladoc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Teladoc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Teladoc to invest in growth at high rates of return. When we think about Teladoc's use of debt, we should always consider it together with cash and equity.

Net Borrowings

(3.44 Million)
Teladoc (4LL) is traded on Frankfurt Exchange in Germany and employs 4,620 people. Teladoc is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 745.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teladoc's market, we take the total number of its shares issued and multiply it by Teladoc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Teladoc classifies itself under Health Care Technology sector and is part of Health Care industry. The entity has 177.47 M outstanding shares. Teladoc has accumulated about 722.63 M in cash with 293.68 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Teladoc Probability Of Bankruptcy
Ownership Allocation
Teladoc shows a total of 177.47 Million outstanding shares. The majority of Teladoc outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Teladoc to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Teladoc. Please pay attention to any change in the institutional holdings of Teladoc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Teladoc Ownership Details

Teladoc Historical Income Statement

At this time, Teladoc's Interest Expense is most likely to increase significantly in the upcoming years. The Teladoc's current Total Revenue is estimated to increase to about 3.1 B, while Operating Income is projected to decrease to (197.3 M). View More Fundamentals

Teladoc Stock Against Markets

Teladoc Stock Analysis Notes

About 76.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 0.6. In the past many companies with similar price-to-book ratios have beat the market. Teladoc recorded a loss per share of 1.06. The entity had not issued any dividends in recent years. Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York. TELADOC HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3652 people. For more info on Teladoc please contact CPA III at 203 635 2002 or go to https://www.teladochealth.com.

Teladoc Quarterly Total Revenue

626.44 Million

Teladoc Investment Alerts

Teladoc generated a negative expected return over the last 90 days
Teladoc has high historical volatility and very poor performance
Teladoc has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 2.57 B. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 1.76 B.
Over 76.0% of the company shares are owned by institutions such as pension funds
Latest headline from news.google.com: HIMS Dips 55.8 percent in 3 Months Should You Still Hold the Stock or Sell - TradingView

Teladoc Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 745.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teladoc's market, we take the total number of its shares issued and multiply it by Teladoc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Teladoc Profitablity

Teladoc's profitability indicators refer to fundamental financial ratios that showcase Teladoc's ability to generate income relative to its revenue or operating costs. If, let's say, Teladoc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Teladoc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Teladoc's profitability requires more research than a typical breakdown of Teladoc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.64)(0.67)
Return On Capital Employed(0.46)(0.48)
Return On Assets(0.33)(0.34)
Return On Equity(0.77)(0.81)

Management Efficiency

Teladoc has return on total asset (ROA) of (0.0348) % which means that it has lost $0.0348 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1542) %, meaning that it generated substantial loss on money invested by shareholders. Teladoc's management efficiency ratios could be used to measure how well Teladoc manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.67. The current Return On Capital Employed is estimated to decrease to -0.48. At this time, Teladoc's Other Assets are most likely to increase significantly in the upcoming years. The Teladoc's current Intangibles To Total Assets is estimated to increase to 0.52, while Non Current Assets Total are projected to decrease to roughly 2 B.
Last ReportedProjected for Next Year
Book Value Per Share 7.87  7.47 
Tangible Book Value Per Share(1.51)(1.58)
Enterprise Value Over EBITDA 66.58  69.91 
Price Book Value Ratio 1.20  1.14 
Enterprise Value Multiple 66.58  69.91 
Price Fair Value 1.20  1.14 
Enterprise Value3.6 B5.9 B
Leadership effectiveness at Teladoc is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin
(0.06)
Profit Margin
(0.09)
Beta
2.144
Return On Assets
(0.03)
Return On Equity
(0.15)

Technical Drivers

As of the 14th of February 2026, Teladoc has the Coefficient Of Variation of (518.36), variance of 11.99, and Risk Adjusted Performance of (0.15). Teladoc technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Teladoc variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if Teladoc is priced more or less accurately, providing market reflects its prevalent price of 4.06 per share.

Teladoc Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Teladoc Tanh Of Price Series is a hyperbolic price transformation function.

Teladoc Outstanding Bonds

Teladoc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teladoc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teladoc bonds can be classified according to their maturity, which is the date when Teladoc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Teladoc Predictive Daily Indicators

Teladoc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teladoc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Teladoc Forecast Models

Teladoc's time-series forecasting models are one of many Teladoc's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teladoc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Teladoc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Teladoc Corporate Directors

Michael GoldsteinIndependent DirectorProfile
David ShedlarzIndependent DirectorProfile
William FristIndependent DirectorProfile
Mark SmithIndependent DirectorProfile
When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Teladoc Stock please use our How to Invest in Teladoc guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Understanding that Teladoc's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Teladoc represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Teladoc's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.